Journal Article Summary
The article investigates the potential risks associated with the use of lamotrigine, an antiepileptic medication, during pregnancy, specifically focusing on the likelihood of orofacial clefts (OC) and other congenital anomalies (CAs). This topic is significant because lamotrigine is often prescribed to women of childbearing age for conditions like epilepsy and bipolar disorder, and understanding its safety profile during pregnancy is crucial for both maternal and fetal health. Previous studies have suggested a possible link between lamotrigine and an increased risk of OC, prompting further research to clarify these associations.
The study utilized a case-malformed control design, analyzing data from 21 population-based congenital anomaly registries across Europe, covering over 10 million births from 1995 to 2011. Researchers compared the incidence of OC and clubfoot in babies exposed to lamotrigine during the first trimester with those who had other nonchromosomal CAs. The findings indicated that while there was a slight increase in the odds of OC and clubfoot among lamotrigine-exposed babies, these associations were not statistically significant. The study estimated that the excess risk of OC was less than 1 in 550 exposed infants, suggesting that lamotrigine may not pose a significant risk for these specific anomalies.
However, the study has limitations, including the inability to estimate the overall risk of congenital anomalies due to the absence of a nonmalformed control group. Additionally, while the findings provide some reassurance regarding lamotrigine's safety, they highlight the need for ongoing monitoring of potential risks. Patients taking lamotrigine during pregnancy should discuss their treatment options and any concerns about congenital anomalies with their healthcare providers to ensure the best outcomes for both mother and baby.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Dolk Helen, Wang Hao, Loane Maria, Morris Joan, Garne Ester, Addor Marie-Claude, Arriola Larraitz, Bakker Marian, et al.. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology 2016. DOI: 10.1212/WNL.0000000000002540. PMID: 27053714. PMCID: PMC4854591.
Featured Pill Pals Product
Lamotrigine 150 mg Tablets --- Generic For Lamictal --- Unichem
Lamotrigine 150 mg Tablets — Generic For Lamictal — Unichem is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
